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Abstract: Human blood dendritic cells (BDC) can be divided into three subsets: plasmacytoid DC (PDC) and two myeloid
subsets - MDC1 and MDC2. Several studies revealed the presence of both MDC and PDC in blood of healthy subjects, however
no precise literature data exist on the number and distribution of BDC in the skin. The aim of our study was to assess the number
and distribution of BDC and their subtypes in the healthy skin. The study included 30 healthy volunteers (age 18-51). Punch
biopsies were taken from the buttock skin from each subject, and immunofluorescent staining was performed using monoclonal
mouse IgG1 antibodies directed against BDCA-1, BDCA-2, BDCA-3 and BDC-4. The BDC were present both in the epidermis
and dermis. PDC were detected mainly in the dermis (mean 1.2 cells per field). Myeloid subtypes were observed mainly in the
middle layers of the epidermis and in the upper part of the dermis (mean 1.8 cells per field). The detection of blood dendritic
cells in the skin proves their role in immune cutaneous surveillance. (www.cm-uj.krakow.pl/FHC)
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Introduction
Human blood dendritic cells (BDC) constitute small
subpopulation of leukocytes and they represent less than
1% of peripheral blood mononuclear cells. According to
recent findings, BDC can be divided into three subsets:
plasmacytoid DC (PDC) and two myeloid subsets -
MDC1 and MDC2 [3]. Myeloid DC recognize several
bacterial components while PDC play an important role
in anti-viral defense. MDC produce high levels of IL-12
and PDC have the capacity to produce high levels of
interferons (IFN-α and IFN-β) [4]. The new panel of
monoclonal antibodies directed against BDCA (blood
dendritic cell antigen), gives an unique opportunity to
exactly define BDC subtypes. PDC express specific
BDCA-2 and BDCA-4 antigens, and are CD123+,
CD11c-, CD4+, CD2- and CD45RO+. MDC1 are CD1c
(BDCA-1)+, Lin-, HLA-DR+, CD11cbright, CD123dim,
CD4+, CD45RO+, CD2+ and express the myeloid li-
neage markers CD13, and CD33, as well as Fc receptors
(CD32, CD64, Fc RI). The second myeloid population,
MDC2, is BDCA-3 positive and expresses similar mar-
kers to the MDC1 population. However, these cells are
CD11clow, CD123dim and CD2- , and lack expression of
the Fc receptors: CD32, CD64 and Fc RI [2].
Several studies revealed the presence of both MDC
and PDC in blood [2, 5] however, no precise literature
data exist on the number and distribution of BDC in the
skin of healthy subjects. Some authors revealed the
presence of PDC in the lesional skin in the course of
various dermatoses [9] while no similar experiments on
the presence of MDC in any conditions were performed.
The aim of our study was to assess the number and
distribution of BDC and its plasmacytoid and myeloid
subsets, defined by anti-BDCA monoclonal antibodies,
in the normally appearing skin in healthy volunteers. 
Materials and methods
The study included 30 healthy volunteers (age 18-51) with either skin
phototype II or III. They were without any diseases and were not
receiving any medications. Each volunteer gave a written informed
consent before entry into the study, and the experimental plan was
approved by the local ethics committee of Medical University of
Łódz´. 
Three mm punch biopsies were taken from the buttock skin from
each subject immediately placed in liquid nitrogen and stored at
-80˚C until analysis. Immunofluorescent staining of cryostat sections
was performed using monoclonal mouse IgG1 antibodies directed
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against BDCA-1 (clone AD5-8E7), BDCA-2 (clone AC144),
BDCA-3 (clone AD5-14H12), all labelled with FITC, and BDC-4
(clone AD-17F6), labelled with PE (all Miltenyi Biotec, Bergish
Gladback, Germany). Skin samples were incubated with a 1:9 dilu-
tion of the antibodies for 60 min at room temperature in the dark.
After washing in phosphate buffered saline, the tissue specimens
were dried and mounted in glycerol. To avoid nonspecific antibody
binding with Fc receptors on other populations of dendritic cells we
used FcR blocking reagent according to manufacturer’s advice. 
Sections were analyzed in a fluorescence microscope (Olympus
Bx40, Olympus Optical Co., Ltd., Tokyo, Japan) coupled to a digital
camera (Camedia, Olympus) and DPX Olympus Software program.
Three sections from each biopsy were examined. The skin specimens
were evaluated in five × 400 high power fields per specimen and the
mean count of each BDC subtype per field was calculated.
Results and discussion
Some data showed the presence of blood dendritic cells,
especially plasmacytoid subset in different skin dis-
eases. They were observed within skin lesions taken
from patients with lupus erythematosus, contact der-
matitis or psoriasis vulgaris and as well in cutaneous
Jessner’s lymphocytic infiltration [9]. 
We do not know any other report showing the
presence of MDC1 and 2 in normal or inflammed skin.
In our study, myeloid subtypes (BDCA-1 and -3) were
observed mainly in the middle layers of the epidermis
and also in the upper part of the dermis (Fig. 1, 2). The
mean number of detected MDC was 1.8 cells per field
(range 1-3 cells). As Langerhans cell (LC) precursors
are myeloid ones, it may also be suggested that under
specific conditions BDCA-1 or BDCA-3 cells become
classic LC with expression of CD1a or langerin [8].
Dzionek et al. [2] revealed BDCA-2 plasmacytoid
cells in lymphoid (inflammed tonsils, lymph nodes and
thymus) and nonlymphoid (testis) tissues. Bangert et al.
[1] found 1.4 PDC/mm2 in the normal human dermis and
none in the epidermis. We also revealed PDC mainly in
the dermis (Fig. 3), however, occasional cells were also
noted in the epidermis. The mean number of detected
PDC (BDCA-2 and BDCA-4) was 1.2 cells per field
(range 0-2 cells).
Our results proved the presence of MDC1 and 2 cells
in human skin, with more prominent number in the
epidermis. The presence of BDC and their subtypes in
the skin under normal conditions may suggest that they
Fig. 1. Myeloid blood dendritic cell in the epidermis, stained with
antibodies directed against BDCA-3 antigen. Direct immunofluores-
cence, × 400.
Fig. 2. Myeloid blood dendritic cell in dermis, stained with anti-
bodies directed against BDCA-3 antigen. Direct immunofluores-
cence, × 400.
Fig. 3. Plasmocytoid blood dendritic cell in dermis, stained with
antibodies directed against BDCA-2 antigen. Direct immunofluores-
cence, × 400.
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play a role in immune surveillance and together with LC
are likely to initiate cellular immune response in the skin.
To our knowledge, this is the first study to show the
number and distribution of BDC and their subtypes in
the healthy human skin by direct immunofluorescence.
Acknowledgements: This study was supported by the European
Union research project number QTL-CT-2001-00212IHA-UV and
research project of Medical University of Łódz´ (502-11-352). We
thank Miltenyi Biotec Bergish Gladback, Germany for providing
samples of anti-BDCA monoclonal antibodies.
References
[ 1] Bangert C, Friedl J, Stary G, Stingl G, Kopp T (2003) Immuno-
pathologic features of allergic contact dermatitis in humans:
participation of plasmacytoid dendritic cells in the pathogenesis
of disease. J Invest Dermatol 121: 1409-1418
[ 2] Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi
S, Buck D W, Schmitz J (2000) BDCA-2, BDCA-3, BDCA-4:
three markers for distinct subsets of dendritic cells in human
peripheral blood. J Immunol 165: 6037-6046
[ 3] Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Fac-
chetti F, Gunter G, Johnston I, Lanzavecchia A, Nagasaka T,
Okada T, Vermi W, Winkles G, Yamamoto T, Zysk M, Yama-
guchi Y, Schmitz J (2001) BDCA-2, a novel plasmocytoid
dendritic cell-specific type II c-type lectin, mediates antigen
capture and is a potent inhibitor of interferon α/β induction. J
Exp Med 194: 1823-1834
[ 4] Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavec-
chia A (2001) Specialization and complementarity in microbial
molecule recognition by human myeloid and plasmacytoid den-
dritic cells. Eur J Immunol 31: 3388-3393
[ 5] Narbutt J, Lesiak A, Zak-Prelich M, Wozniacka A, Sysa-Jedrze-
jowska A, Tybura M, Robak T, Smolewski P (2004) Distribu-
tion of peripheral blood dendritic cells assayed by a new panel
of anti-BDCA monoclonal antibodies in healthy representatives
of the Polish population. Cell Mol Biol Lett 9: 497-509
[ 6] Shortman K, Caux C (1997) Dendritic cell development:
multiple pathways to nature’s adjuvants. Stem Cells 15: 409-
419
[ 7] Steinmann R, Cohn Z (1973) Identification of a novel cell type
in peripheral lymphoid organs of mice. J Exp Med 137: 1142-
1162
[ 8] Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K,
Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C, Schmitt D,
Davoust J, Caux C, Lebecque S, Saeland S (2000) Langerin, a
novel C-type lectin to Langerhans cells, is an endocytic receptor
that induces the formation of Birbeck granules. Immunity 12:
71-78
[ 9] Wollenberg A, Wagner M, Gunther S, Towarowski A, Tuma E,
Moderer M, Rothenfusser S, Wetzel S, Endres S, Hartmann G
(2002) Plasmacytoid dendritic cells: a new cutaneous dendritic
cell subset with distinct role in inflammatory skin diseases. J
Invest Dermatol 119: 1096-1102
Received:June 16, 2005
Accepted after revision: September 2, 2005
Blood dendritic cells in human skin 63
